Search research articles
Contact Us
Filters
Showing results (31-40 of 501) with videos related to
Page
of 51
Sort By:
Research Integrity and Peer Review
|
July 10, 2025
Misidentified cell lines: failures of peer review, varying journal responses to misidentification inquiries, and strategies for safeguarding biomedical research
Ralf Weiskirchen
Hepatology (Baltimore, Md.)
|
July 31, 2008
A yellow bullet against the drivers of hepatic fibrogenesis
Ralf Weiskirchen, Frank Lammert
Annals of Translational Medicine
|
May 14, 2021
Unresolved basic issues in hepatology
Ralf Weiskirchen, Wolfgang Stremmel
Medical Sciences (Basel, Switzerland)
|
November 24, 2025
Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders
Ralf Weiskirchen, Amedeo Lonardo
International Journal of Molecular Sciences
|
July 12, 2025
The Ovary-Liver Axis: Molecular Science and Epidemiology
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology
|
February 13, 2025
How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, Amedeo Lonardo
Metabolites
|
August 28, 2024
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics
Amedeo Lonardo, Ralf Weiskirchen
Journal of Cell Communication and Signaling
|
July 1, 2024
The signaling pathways in obesity-related complications
Preethi Chandrasekaran, Ralf Weiskirchen
Open Medicine (Warsaw, Poland)
|
April 13, 2026
Mitochondrial medicine in obesity: a scoping review
Amedeo Lonardo, Ralf Weiskirchen
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
January 23, 2003
The CRP/MLP/TLP family of LIM domain proteins: acting by connecting
Ralf Weiskirchen, Kalle Günther
Page
of 51
Search research articles
Search
Showing results (31-40 of 501) with videos related to
Sort By:
Page
of 51
Research Integrity and Peer Review
|
July 10, 2025
Misidentified cell lines: failures of peer review, varying journal responses to misidentification inquiries, and strategies for safeguarding biomedical research
Ralf Weiskirchen
Hepatology (Baltimore, Md.)
|
July 31, 2008
A yellow bullet against the drivers of hepatic fibrogenesis
Ralf Weiskirchen, Frank Lammert
Annals of Translational Medicine
|
May 14, 2021
Unresolved basic issues in hepatology
Ralf Weiskirchen, Wolfgang Stremmel
Medical Sciences (Basel, Switzerland)
|
November 24, 2025
Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders
Ralf Weiskirchen, Amedeo Lonardo
International Journal of Molecular Sciences
|
July 12, 2025
The Ovary-Liver Axis: Molecular Science and Epidemiology
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology
|
February 13, 2025
How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, Amedeo Lonardo
Metabolites
|
August 28, 2024
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics
Amedeo Lonardo, Ralf Weiskirchen
Journal of Cell Communication and Signaling
|
July 1, 2024
The signaling pathways in obesity-related complications
Preethi Chandrasekaran, Ralf Weiskirchen
Open Medicine (Warsaw, Poland)
|
April 13, 2026
Mitochondrial medicine in obesity: a scoping review
Amedeo Lonardo, Ralf Weiskirchen
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
January 23, 2003
The CRP/MLP/TLP family of LIM domain proteins: acting by connecting
Ralf Weiskirchen, Kalle Günther
Page
of 51